We conducted both conventional pairwise and Bayesian network meta-analyses to compare the clinical properties of supraglottic airway devices in children. We searched six databases for randomised clinical trials. Our primary endpoints were oropharyngeal leak pressure, risk of insertion failure at first attempt, and blood staining risk. The risk of device failure, defined as the abandonment of the supraglottic airway device and replacement with a tracheal tube or another device, was also analysed. Sixty-five randomised clinical trials with 5823 participants were identified, involving 16 types of supraglottic airway device. Network meta-analysis showed that the i-gel TM , Cobra perilaryngeal airway TM and Proseal laryngeal mask airway (LMA â -Proseal) showed statistically significant differences in oropharyngeal leak pressure compared with the LMA â -Classic, with mean differences (95% credible interval, CrI) of 3.6 (1.9-5.8), 4.6 (1.7-7.6) and 3.4 (2.0-4.8) cmH 2 O, respectively. The i-gel was the only device that significantly reduced the risk of blood staining of the device compared with the LMA-Classic, with an odds ratio (95%CrI) of 0.46 (0.22-0.90). The risk (95%CI) of device failure with the LMA-Classic, LMA â -Unique and LMA-Proseal was 0.36% (0.14-0.92%), 0.49% (0.13-1.8%) and 0.50% (0.23-1.1%), respectively, whereas the risk (95%CI) of the i-gel and PRO-Breathe was higher, at 3.4% (2.5-4.7%) and 6.0% (2.8-12.5%), respectively. The risk, expressed as odds ratio (95%CrI), of insertion failure at first attempt, was higher in patients weighing < 10 kg at 5.1 (1.6-20
Introduction
Supraglottic airway devices have been widely used for airway management during elective surgery in children. There are many types of supraglottic airway devices available for children. Many randomised controlled trials have compared clinical properties such as oropharyngeal leak pressure, insertion success/failure at first attempt, or complications, between a number of different types of such devices. In addition, systematic reviews comparing the classic laryngeal mask airway, LMA â -Classic, with the LMA â Proseal [1] , and with the i-gel TM [2] [3] [4] have been published. However, randomised trials have only been conducted on a small proportion of the many possible comparisons between pairs of supraglottic airway devices, making it difficult to determine the optimal supraglottic airway device.
Network meta-analysis, also known as mixed treatment comparison, combines both direct (head-to-head comparison) and indirect comparison (inter-trial comparison through a common comparator) for multiple treatment comparisons. Network meta-analysis can provide information estimating the effect between any of two comparisons even when these were not directly compared in randomised trials [5] . The usefulness of network meta-analysis has been demonstrated in various medical fields [6] [7] [8] [9] [10] [11] .
The aim of the current study was to compare the clinical properties of different types of supraglottic airway devices for children.
Methods
We conducted Bayesian network meta-analyses. In addition, we conducted traditional pairwise metaanalyses to confirm the potential difference in results between pairwise and network analyses. We referred to the PRISMA extension statement for reporting network meta-analysis [12] , which is recommended when conducting network meta-analysis [13] , the PRISMA statement [14, 15] and the Cochrane Handbook [16] .
We searched the Cochrane database (CENTRAL), Embase, Web of Science, and MEDLINE up to July 1, 2016 ; the reference lists of the retrieved full articles were also searched. Furthermore, we conducted a search of clinicaltrials.gov and the UMIN Clinical Trials Registry to identify on-going studies. The search strategy for PubMed is shown in the online Supporting Information. Two reviewers independently evaluated all potentially eligible studies. The full-text versions of potentially eligible studies chosen by at least one reviewer were assessed. Any disagreement was resolved by discussion.
All randomised trials comparing any types of supraglottic airway device in children were included in this meta-analysis. We excluded case reports, reviews, manikin studies and animal studies. Eligibility was not restricted by language. The primary end-points of our study were oropharyngeal leak pressure, risk of insertion failure at first attempt and risk of blood staining of the device. The post-hoc secondary end-point, not predefined in the protocol, was the risk of device failure; this was defined as the abandonment of the supraglottic airway device and replacement with an tracheal tube or another device.
We extracted data on patient characteristics, type of anaesthesia, study design, financial support and primary and secondary end-points. When oropharyngeal leak pressure was assessed at several time-points, we extracted the data recorded immediately after supraglottic airway device insertion. When oropharyngeal leak pressure was assessed in different head positions, we extracted the data recorded in the neutral head position. We excluded crossover trials for analysing the risk of blood staining on the device because the carryover effect was considered significant. When analysing device failure, we excluded studies in which the supraglottic airway devices were not used for airway management during surgery. When a median value with range was presented instead of a mean with standard deviation, the mean with standard deviation was calculated using the method reported by Hozo et al. [17] . Standard deviations were estimated as interquartile range/1.35 when a range was not reported. Data extraction was conducted by two reviewers independently. Any disagreement was resolved by discussion.
We used the Cochrane method for assessing risk of bias [16] to evaluate the quality of the studies. We assessed the Cochrane 'risk of bias' in the following domains: 'random sequence generation'; 'allocation concealment'; 'blinding' (participants, anaesthetists and end-point assessors); 'incomplete data'; 'selective reporting of outcomes' and potential 'other biases'. Two reviewers independently assessed the risk of bias for each randomised trial.
We evaluated the configuration of the network [18] by generating a network graph. A network graph included nodes representing the devices, with 'edges' (lines) connecting the nodes if head-to-head comparisons between nodes (in this case, airway devices) existed.
We conducted both traditional pairwise and Bayesian network meta-analyses. For traditional pairwise meta-analyses, a random-effects model (DerSimonian and Laird method [19] ) was used. We calculated the combined estimates of mean difference with 95% confidence intervals (CI) for continuous data, and odds ratio (OR) with 95%CI for dichotomous data. Heterogeneity was quantified with the I 2 statistic. Small study effects were assessed using a funnel plot and a regression asymmetry test [20] when the number of trials was greater than nine. Small study effects were considered present if p < 0.1 in the asymmetry test. We performed network meta-analyses using a random-effects model. We used the Bayesian model with Markov chain Monte Carlo simulation [21] . We referred to the 'technical support document' [21] [22] [23] from the Decision Support Unit of National Institute for Health and Clinical Excellence for the WinBUGS/ OpenBUGS code. The full methodology for the Bayesian network meta-analysis is reported in the online Supporting Information. In brief, we used noninformative priors (uniform prior distributions for parameters of between-studies variance). The point estimates of the effects and the 95% credible intervals (CrIs) were obtained from the posterior distribution. A CrI is also known as a Bayesian confidence interval, and can be interpreted in a similar way to a confidence interval in frequentist statistics.
We evaluated the consistency between indirect and direct comparisons by comparing the deviance information criteria between the inconsistency and the consistency model [23] . In addition, we planned to examine local closed-loop inconsistency using the Bucher method [8] when the deviance information criteria in the consistency model were five or more greater than that in the inconsistency model.
We conducted sensitivity analyses after restricting to high-quality studies (i.e. studies with low risk of bias on both the sequence generation and allocation concealment domains). We also conducted sensitivity analyses using an inverse-gamma distribution instead of uniform distribution for the non-informative prior distribution for the between-studies variance. We performed Bayesian meta-regression analyses [22] to explore the relationship between each end-point and: whether a neuromuscular blocking agent was administered before supraglottic airway device insertion; whether patient body weight was less than 10 kg; and whether oropharyngeal leak pressure was measured by the manometric stability technique (this meta-regression analysis was performed only for oropharyngeal leak pressure). We conducted an additional subgroup analysis for risk of insertion failure at first attempt after restricting to studies where patient body weight was less than 10 kg. We decided to conduct this subgroup analysis, although it was not pre-specified in our protocol, because the results of the meta-regression analysis indicated that risk of insertion failure at first attempt was greater in patients with body weight less than 10 kg. All results were reported as odds ratio or mean difference with 95%CrI. If the 95%CI and/or CrI included a value of 0 for mean difference, or a value of 1 for the odds ratio, we considered the difference not statistically significant. For the reference device (the LMA-Classic), we calculated the combined mean (SD) of the oropharyngeal leak pressure, the combined incidence of the first insertion failure, and the combined incidence of blood staining. A meta-analysis of device failure could not be performed because the incidence of device failure was zero in all arms of 46 of the 59 trials. We calculated the combined failure incidence for each supraglottic airway device. The clinically acceptable threshold for the upper limit of 95%CI of the incidence of the device failure was set at 2.5% [24] . R statistical software (v. 3.0.2, R Foundation for Statistical Computing, Vienna, Austria) was used for the pairwise meta-analyses while the OpenBUGS [25] package was used for the network meta-analyses with a Bayesian method.
Results
A comprehensive search of the six databases described above yielded a total of 2410 citations. The full texts of 118 articles were examined in detail. We included 65 articles in this network meta-analysis (Fig. 1) . Out of the included articles, 61 were in English, one was in Korean [37] , one was in Chinese [83] , one was in French [36] and one was in German [49] .
The Table S1 (Supporting Information online).
The risk of bias of each domain for the randomised trials is summarised in Table S2 in the online Supporting Information. A low risk of bias in both the 'random sequence generation' and 'allocation concealment' domains was noted in 34 of 65 studies. Anaesthetists involved in airway management were not blinded in any of the studies. Data on oropharyngeal leak pressure were obtained from 5333 children in 62 trials, with 15 types of supraglottic airway device included. The network graph is presented as Fig. S1 (online Supporting Information). The results of the oropharyngeal leak pressure network meta-analysis are shown in Fig. 3 and Table 1 . In Table 1 , the device name is provided in the diagonal cells. The results of the comparison should be read from left to right: each cell shows the result of comparison between the device named in its column and the device in its intersecting row. The results from all comparison pairs are shown in the lower triangle of Table 1 (black), whereas the results restricted to analysis of studies at low risk of bias are in the upper triangle (blue). There are 17 comparison pairs with statistically significant differences in oropharyngeal leak pressure. Among these, Laryngeal Tube, LMA-Proseal, i-gel and Cobra perilaryngeal airway showed significantly greater oropharyngeal leak pressure than other supraglottic airway devices (Table 1 ). Figure 3 presents a forest plot for oropharyngeal leak pressure of LMA-Classic vs. other supraglottic airway devices; LMA-Classic was selected as the reference device. The combined mean (SD) oropharyngeal leak pressure for the LMA-Classic was 21.7 (5.6) cmH 2 O. The oropharyngeal leak pressures of LMA-Proseal, i-gel, Laryngeal Tube and Cobra perilaryngeal airway were higher than that of LMA-Classic, with mean differences (95%CrI) of 3.4 (2.0-4.8), 3.6 (1.9-5.8), 6.9 (2.7-10.9) and 4.6 (1.7-7.6) cmH 2 O, respectively. The model fit of the consistency model (deviance information criteria = 406.6) was similar to that of the inconsistency model (deviance information criteria = 407.9). The sensitivity analysis restricting to the high-quality trials did not change the results except for Laryngeal Tube, Softseal and Ambu AuraGain (upper triangle of Table 1 ). There was no highquality trial for Laryngeal Tube, Softseal and Ambu AuraGain, and consequently, we could not estimate the oropharyngeal leak pressure of these two devices in the sensitivity analysis. The sensitivity analysis examining the influence of non-informative prior distribution for the between-studies variance did not alter the results. In the meta-regression analysis, all coefficients (i.e. use of neuromuscular blocking agent, mean body weight < 10 kg and oropharyngeal leak pressure measurement technique) were not statistically significant (Table S3 , Supporting Information). In addition, between-trial standard deviation, representing heterogeneity between studies, did not change in the metaregression analysis.
The traditional pairwise meta-analysis provided 29 comparisons, whereas the network meta-analysis provided 105 comparisons. The 95%CI/CrI of all 29 comparisons overlapped between pairwise and network analyses. The detailed results of the pairwise metaanalysis are presented in Table S4 (Supporting Information).
Data on insertion failure at the first attempt were obtained from 5666 children in 62 trials, with 16 types of supraglottic airway device included (the network graph is presented as Fig. S2 in the online Supporting Information). The results of the network meta-analysis for insertion failure at first attempt are presented in Fig. 3 below and also in Table S5 of the Supporting Information. The risks of insertion failure at first attempt in all comparison pairs are presented in the lower triangle of Table S5 (Supporting Information). The risk of insertion failure at first attempt was low, with an OR (95%CrI) of 0.23 (0.06-0.89) for the PROBreath compared with the LMA-Classic. Figure 3 shows a forest plot for insertion failure at first attempt for the LMA-Classic vs. other supraglottic airway devices. The combined incidence (95%CI) of first insertion failure for the LMA-Classic was 11.7% (9.9-13.7%). The model fit of the consistency model (deviance information criteria = 551.7) was better than that of the inconsistency model (deviance information criteria = 565.3). The sensitivity analysis restricting to the high-quality trials widened the CrIs (upper triangle Figure 3 Forest plots of meta-analyses of oropharyngeal leak pressure, risk of insertion failure at first attempt and risk of blood staining for LMA-Classic vs. other supraglottic airway devices. LMA, laryngeal mask airway; Cobra, Cobra perilaryngeal airway; airQ-SP, self-pressurised air-Q; CrI, credible interval; OR, odds ratio; MD, mean difference; SLIPA, Streamlined Liner of Pharyngeal Airway. of Table S5 , Supporting Information). There was no high-quality trial for Softseal and Ambu AuraGain; therefore, we could not estimate the risk of insertion failure at first attempt of these two devices. The sensitivity analysis examining the influence of non-informative prior distribution for the between-studies variance did not alter the results. The coefficient of the metaregression for mean patient body weight < 10 kg was statistically significant (Table S3 , Supporting Information). The risk of insertion failure at first attempt was significantly higher in patients with mean body weight < 10 kg, with an OR (95%CrI) of 5.1 (1.6-20.1). The between-trial standard deviation decreased from 0.38 to 0.26 when considering the difference of body weight, indicating that 32% of the heterogeneity between studies could be explained by the difference in body weight. Of the eight trials [32, 38, 51, 67, 70, 76, 77, 80] with a mean patient body weight < 10 kg, six [51, 67, 70, 76, 77, 80] compared two of the following three supraglottic airway devices: LMA-Classic, LMA-Proseal or i-gel. The results of the subgroup analysis indicated that there were no statistically significant differences among the three supraglottic airway devices (Table S6 , Supporting Information). The traditional pairwise meta-analysis provided 30 comparisons, whereas the network meta-analysis provided 120 comparisons. The 95%CI/CrI of all the 30 comparisons overlapped between pairwise and network analyses. The detailed results of the pairwise meta-analysis are presented in Table S4 (Supporting Information).
Data on the risk of blood staining of the device were obtained from 4387 children in 45 trials, with 15 types of supraglottic airway devices included. A network graph is presented in Fig. S3 in the Supporting Information). The results of the network meta-analysis for risk of blood staining on supraglottic airway devices are presented in Fig. 3 and in Table S7 (Supporting Information). The results of risk of blood staining in all comparison pairs are shown in the lower triangle of Table S7 . The risk of blood staining was low with the i-gel compared with the LMA-Classic and LMA-Proseal, with odds ratios (95%CrI) of 0.46 (0.22-0.90) and 0.35 (0.17-0.70), respectively. Figure 3 shows a forest plot for the LMA-Classic vs. other supraglottic airway devices. The combined incidence (95%CI) of blood staining on LMA-Classic was 7.5% (5.9-9.4%). The model fit of the consistency model (deviance information criteria = 373.5) was better than that of the inconsistency model (deviance information criteria = 378.4). The sensitivity analysis restricting to the high-quality trials widened the 95%CrIs in all comparison pairs. Although the statistical significance in the comparisons i-gel vs. LMA-Classic and i-gel vs. LMAProseal disappeared, the direction of the effects did not change for both comparison pairs (see upper triangle of Table S7 in the Supporting information). There was no study with a 'low' risk of bias for Softseal, and consequently we could not estimate the risk of blood staining for Softseal. The sensitivity analysis examined the influence of non-informative prior distribution for the between-studies variance did not alter the results. In the meta-regression analysis, none of the coefficients was statistically significant (Table S3 , Supporting Information).
The traditional pairwise meta-analysis provided 23 comparisons, whereas the network meta-analysis provided 105 comparisons. The 95%CI/CrI of all the 23 comparisons overlapped between pairwise and network analyses. The detailed results of the pairwise metaanalysis are presented in Table S4 (Supporting  Information) .
We collected data on the risk of device failure on 5379 children in 59 trials, with 16 types of supraglottic airway devices included. We could not conduct a meta-analysis for the risk of device failure because the incidence of device failure was zero in all arms of the 46 trials. Device failure occurred in 73 of 5379 cases or 1.4% (95%CI 1.1-1.7%) in total. The upper limit of the 95%CI of the incidence of device failure was less than 2.5% for LMA-Classic, LMA-Proseal and LMAUnique. In contrast, the lower limit of the 95%CI of the incidence of device failure was equal or more than 2.5% for i-gel and PRO-Breathe (Table 2 ).
Discussion
In this study, we conducted Bayesian network metaanalyses to compare the clinical properties of various types of supraglottic airway devices in children. The main findings were as follows: the i-gel, LMA-Proseal and Cobra perilaryngeal airway had a higher oropharyngeal leak pressure than the other devices; the risk of insertion failure at first attempt was significantly higher in patients with body weight < 10 kg than in heavier children; the risk of blood staining on supraglottic airway devices was low with the i-gel; and the risk of device failure may be low with LMA-Proseal, LMA-Classic and LMA-Unique, but high with i-gel and PRO-Breathe.
The higher oropharyngeal leak pressure with the igel, LMA-Proseal and Cobra perilaryngeal airway are consistent (at least for the i-gel and LMA-Proseal) with previous pairwise meta-analyses which compared these two supraglottic airway devices with the LMA-Classic [1, 2] . The higher oropharyngeal leak pressure is clinically relevant especially when positive pressure ventilation is used during surgery. A recent investigation for practice patterns of using supraglottic airway devices reported that 53% of anaesthesiologists used pressure support ventilation, while 25% of anaesthesiologists administered neuromuscular blocking agents [91] . We suggest that the i-gel, LMA-Proseal and Cobra perilaryngeal airway are advantageous in these situations. Our results also showed that the Laryngeal Tube had a higher oropharyngeal leak pressure than other supraglottic airway devices. However, we could not confirm these results in the sensitivity analysis. Further highquality randomised trials are needed to confirm the Laryngeal Tube results.
The risk of insertion failure at first attempt was significantly higher in patients with a body weight < 10 kg (OR = 5.1). In addition, the meta-regression analysis indicated that the difference in patients' body weight caused the heterogeneity between the studies. Previous observational studies have also reported that the failure rate of LMA was high in younger patients [92, 93] . Infants have a larger tongue and epiglottis in relation to their mandible compared with adults. In addition, the glottis lies higher and more anteriorly in infants than in adults. Since the supraglottic airway devices for children are scaled-down versions of the adult forms [94] , differences in the airway anatomy among newborns, infants and young children may partly explain the higher risk of insertion failure in patients with body weight < 10 kg. We failed to find a supraglottic airway device with low risk of insertion failure at first attempt for such light patients. As there were only six trials, we could not include in the subgroup network meta-analysis patients with a body weight less than 10 kg. Further trials on these patients are therefore required.
Our results showed that the risk of blood staining of the device was significantly lower with the i-gel compared with LMA-Classic and LMA-Proseal. The blood staining on supraglottic airway devices indicates oral or pharyngeal mucosal injury caused by the insertion or removal of the device. The unique soft gel-like cuff of the i-gel, which is constructed from medical grade thermoplastic elastomer [95] , may be the reason for the low risk of blood staining on this device. The result did not change in the sensitivity analysis, although there was no statistical significance due to the wide 95%CrI. However, the lower risk of blood staining observed with the i-gel does not directly imply that this device provides better patient-reported endpoints such as postoperative sore throat. Therefore, these results should be cautiously applied to clinical practice.
Device failure was a rare but important safety endpoint [96] . While the incidence was zero in most studies, a small trial showing zero events may be meaningless [24] . Since most trials reported zero events in all study arms, we were unable to conduct a meta- analysis, but could observe the incidence of device failures in a randomised trial setting. We observed a total of 73 device failures in 5379 cases or 1.4% (95%CI 1.1-1.7%) failure rate. The results were consistent with previous large-scale observational studies in which the risk of device failure was reported as 0.86% [93] and 1.1% [97] in paediatric and adult patients, respectively. However, the upper limit of the 95%CI of the incidence of device failure was clinically acceptable (< 2.5% [24] ) only with LMA-Classic, LMA-Proseal and LMA-Unique. In addition, we observed a relatively high device failure rate (95%CI) with i-gel at 3.4% (2.5-4.7%) and PRO-Breathe at 6.0% (2.8-12.5%), respectively. A previous systematic review including both randomised and non-randomised studies of the igel [4] reported that the failure rate was < 5% in all studies. However, none of the studies found the upper limit of the 95%CI of the failure rate to be lower than the clinically acceptable level (i.e. 2.5%) due to inadequate sample sizes for the assessment of rare events. Therefore, a large-scale observational study is required to evaluate the failure rate of the i-gel. The strength of network meta-analysis lies in its ability to provide the results of indirect comparisons. Firstly, it is possible to estimate the effect between comparison pairs that have not been directly compared before. In the current analyses, for example, there were only 29 direct comparisons for oropharyngeal leak pressure, but we could obtain the results of 105 comparison pairs by network meta-analysis. Secondly, when direct comparisons have been performed previously, there is a possibility that more precise results can be obtained by combining the results of the direct and indirect comparisons. However, in a network meta-analysis, it is essential to evaluate the consistency between direct and indirect comparisons since there is an assumption of consistency in the network metaanalysis. The indirect comparison of device A vs. B can be estimated through a common comparator C using the following consistency equation: the indirect comparison of A vs. B = (the direct comparison of C vs. B) -(the direct comparison of C vs. A). When the direct comparison of A vs. B is available, we can evaluate the consistency between the direct and indirect comparisons. In this study, we evaluated the consistency between the direct and indirect comparisons by comparing the model fit between the consistency and inconsistency model, and we adopted the consistency model. Further details are available elsewhere [23, 98, 99] .
The present study has some limitations. Firstly, in the randomised trials, it was impossible to blind those who inserted the supraglottic airway devices; therefore, the results could be biased. Subjectively assessed endpoints are more subject to bias due to the lack of blinding than objectively assessed end-points [100] . Therefore, we avoided estimating subjectively assessed end-points such as ease of insertion. Secondly, headto-head trials were not conducted for many comparison pairs, as shown in the network graph. The studies of the LMA-Classic, LMA-Proseal and i-gel included approximately 1000 patients each; however, the number of randomly assigned patients was insufficient in other supraglottic airway devices. Consequently, although many indirect comparisons were possible, most of these had very wide credibility intervals (CrI), which made the comparison clinically meaningless. Therefore, further randomised trials comparing supraglottic airway device pairs in which randomised trials have not so far been conducted are required. Our network graph could be used to identify such comparison pairs, and the results of the indirect comparisons could be used to estimate the effect size for sample size calculation in future trials. Thirdly, there was no highquality study for the Laryngeal Tube. Our findings showed that the Laryngeal Tube had a higher oropharyngeal leak pressure compared with other supraglottic airway devices. However, the results for this device should be evaluated further in high quality randomised trials.
In conclusion, we compared the clinical properties of 16 types of supraglottic airway devices in children. The oropharyngeal leak pressure was higher in the igel, LMA-Proseal and Cobra perilaryngeal airway, and the risk of blood staining on device was lowest in the i-gel. The risk of device failure may be low with LMAProseal, LMA-Classic and LMA-Unique, but high with the i-gel. Based on the outcomes chosen, we suggest that the LMA-Proseal would be the best supraglottic airway device for children because LMA-Proseal had a high oropharyngeal leak pressure and low risk of device failure. Although i-gel had a high oropharyngeal leak pressure and low risk of blood staining on device, the risk of device failure should be evaluated before its routine use can be recommended. 
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